Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review

The present review focuses on the vascular basement membrane (VBM) and its relationship to the lesions of Alzheimer's disease (AD). Examination of the fine structure of the microvasculature reveals AD-associated VBM alterations, which include both thickening and vacuolization. Immunocytochemistry confirms that all three intrinsic VBM components [collagen type IV, laminin, and heparan sulfate proteoglycan (HSPG)] outline the capillary bed, which is pathologically altered in AD patients (microangiopathy). Ultrastructural analyses of AD tissue samples demonstrate that HSPG's normal staining pattern is disrupted on the endothelial surface of the VBM in brain regions affected by Alzheimer lesions. Similarly altered VBM is reported to occur in the kidney of patients with diabetes mellitus, where it is associated with a leakage of protein. All three VBM components immunolabel capillaries, amyloid and plaque-associated glial processes, suggesting a link between microangiopathy and senile plaque formation. In addition, the consistent colocalization of HSPG with several forms of amyloid implies an involvement in amyloidogenesis. Finally, the neurotrophic effects of beta-amyloid, combined with neurite-promoting effects of laminin and HSPG, could create a strong focus for an aberrant sprouting response. Such a response is postulated to result in plaque-associated degenerating neurites. Thus, VBM components could serve as a nidus for plaque formation, playing a role in the development of neuritic as well as amyloidotic elements.

[1]  J. Hardy,et al.  An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease , 1986, Neurobiology of Aging.

[2]  W. Robison Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors. , 1988, Advances in experimental medicine and biology.

[3]  Sanford L. Palay,et al.  The fine structure of the nervous system: The neurons and supporting cells , 1976 .

[4]  G. V. Van Hoesen,et al.  Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease , 1987, Annals of neurology.

[5]  A. Vaheri,et al.  Laminin is induced in astrocytes of adult brain by injury. , 1984, The EMBO journal.

[6]  D. Abrahamson,et al.  Proteinuria and structural alterations in rat glomerular basement membranes induced by intravenously injected anti-laminin immunoglobulin G , 1982, The Journal of experimental medicine.

[7]  Sandra R. Smith,et al.  An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Timpl,et al.  In vivo localization and pathological effects of passively transferred antibodies to type IV collagen and laminin in mice. , 1982, Clinical immunology and immunopathology.

[9]  D. Price,et al.  Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. , 1987, Science.

[10]  K M Yamada,et al.  Cell surface interactions with extracellular materials. , 1983, Annual review of biochemistry.

[11]  W. Pardridge,et al.  Journal of Cerebral Blood Flow and Metabolism Antibodies to Blood-brain Barrier Bind Selectively to Brain Capillary Endothelial Lateral Membranes and to a 46k Protein , 2022 .

[12]  R. Spiro,et al.  Effect of Diabetes on the Glycosaminoglycan Component of the Human Glomerular Basement Membrane , 1982, Diabetes.

[13]  G. Glenner Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia). , 1979, Medical hypotheses.

[14]  A. Negro,et al.  Macromolecular organization and functional architecture of basement membranes. , 1984, Applied pathology.

[15]  M. Kidd ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY. , 1964, Brain : a journal of neurology.

[16]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[17]  Thomas We,et al.  Brain macrophages: questions of origin and interrelationship. , 1988 .

[18]  S. Palay,et al.  The Fine Structure of the Nervous System: Neurons and Their Supporting Cells , 1991 .

[19]  H. Thoenen,et al.  The heparin‐binding domain of laminin is responsible for its effects on neurite outgrowth and neuronal survival. , 1984, The EMBO journal.

[20]  L. Autilio‐Gambetti,et al.  Paired helical filaments: Do they contain neurofilament epitopes? , 1986, Neurobiology of Aging.

[21]  Z. Nagy,et al.  Charge-related alterations of the cerebral endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[22]  E. Lillehoj,et al.  Normal and abnormal aspects of proteinuria. Part I: Mechanisms, characteristics and analyses of urinary protein. Part II: Clinical considerations. , 1986, Experimental pathology.

[23]  C. Cotman,et al.  Senile plaques as aberrant sprout-stimulating structures , 1986, Experimental Neurology.

[24]  H. Chui,et al.  Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease , 1990, Neuroscience Letters.

[25]  R. Kisilevsky,et al.  A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[26]  C. Cotman,et al.  Amyloid beta protein enhances the survival of hippocampal neurons in vitro. , 1989, Science.

[27]  M. Hart,et al.  Differential opening of the brain endothelial barrier following neutralization of the endothelial luminal anionic charge in vitro. , 1987, Journal of neuropathology and experimental neurology.

[28]  G. Cole,et al.  Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein. , 1988, Science.

[29]  S. Radin,et al.  Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio. , 1989, Ophthalmic research.

[30]  M. Graeber,et al.  Identity of ED2‐positive perivascular cells in rat brain , 1989, Journal of neuroscience research.

[31]  P. Davies,et al.  Dementia of the Alzheimer type. , 1980, Annual review of neuroscience.

[32]  H. Chui,et al.  Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease , 1990, Brain Research.

[33]  J. Roder,et al.  Neuronal proteoglycans: biosynthesis and functional interaction with neurons in vitro , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  J. Wegiel,et al.  Ultrastructural Studies of the Cells Forming Amyloid Fibers in Classical Plaques , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[35]  G. Glenner,et al.  Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Lander,et al.  Purification of a factor that promotes neurite outgrowth: isolation of laminin and associated molecules , 1985, The Journal of cell biology.

[37]  W. Oldendorf,et al.  Blood-brain barrier: interface between internal medicine and the brain. , 1986, Annals of internal medicine.

[38]  H. Stadler,et al.  Identification of a heparan sulphate‐containing proteoglycan as a specific core component of cholinergic synaptic vesicles from Torpedo marmorata. , 1982, The EMBO journal.

[39]  C. P. Hughes,et al.  Nosologic problems in dementia , 1973, Neurology.

[40]  D. Selkoe,et al.  Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease , 1989, Nature.

[41]  M. Esiri,et al.  Cerebral amyloid angiopathy in dementia and old age. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[42]  C. P. Leblond,et al.  Identification of microglia in light and electron microscopy , 1969, The Journal of comparative neurology.

[43]  H. Wiśniewski,et al.  Evidence for Blood‐Brain Barrier Changes in Senile Dementia of the Alzheimer Type (SDAT) , 1982, Annals of the New York Academy of Sciences.

[44]  G. Glenner,et al.  β-PLEATED SHEET FIBRILS A COMPARISON OF NATIVE AMYLOID WITH SYNTHETIC PROTEIN FIBRILS , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[45]  R. Kisilevsky From arthritis to Alzheimer's disease: current concepts on the pathogenesis of amyloidosis. , 1987, Canadian journal of physiology and pharmacology.

[46]  P. Amenta,et al.  The basement membrane in pathology. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[47]  B. Deurs Observations on the blood-brain barrier in hypertensive rats, with particular reference to phagocytic pericytes , 1976 .

[48]  D. Gospodarowicz,et al.  Characterization of a factor that promotes neurite outgrowth: evidence linking activity to a heparan sulfate proteoglycan , 1982, The Journal of cell biology.

[49]  C. Wilson,et al.  Immunopathology and glomerulonephritis. , 1974, Annual review of medicine.

[50]  L. Reichardt,et al.  Appearance and distribution of neuronal cell surface and synaptic vesicle antigens in the developing rat superior cervical ganglion , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[51]  R. Martins,et al.  Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. , 1985, The EMBO journal.

[52]  A. Lander,et al.  Laminin is associated with the "neurite outgrowth-promoting factors" found in conditioned media. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Stow,et al.  Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening , 1986, The Journal of experimental medicine.

[54]  Bradbury Mw The structure and function of the blood-brain barrier. , 1984 .

[55]  T. Miyakawa,et al.  The relationship between senile plaques and cerebral blood vessels in Alzheimer’s disease and senile dementia , 1982, Virchows Archiv. B, Cell pathology including molecular pathology.

[56]  H. Kleinman,et al.  Alterations in the Basement Membrane (Heparan Sulfate) Proteoglycan in Diabetic Mice , 1982, Diabetes.

[57]  K. Iqbal Biology of Alzheimer's disease through biochemistry of tangles and plaques , 1986, Neurobiology of Aging.

[58]  C. C. Clark,et al.  Biochemistry and metabolism of basement membranes. , 1979, International review of cytology.

[59]  R. Cotran,et al.  Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins , 1975, The Journal of cell biology.

[60]  H. Fillit,et al.  Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type. , 1987, Journal of gerontology.

[61]  S. Rapoport,et al.  Examination of Blood — Brain Barrier Permeability in Dementia of the Alzheimer Type with [68Ga]EDTA and Positron Emission Tomography , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[62]  G. Goldstein,et al.  In Vitro Studies of the Blood‐Brain Barrier Using Isolated Brain Capillaries and Cultured Endothelial Cells a , 1986, Annals of the New York Academy of Sciences.

[63]  H. Kleinman,et al.  Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[64]  D. Rifkin,et al.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture , 1989, The Journal of cell biology.

[65]  J. D. Gregory,et al.  Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan , 1985, The Journal of experimental medicine.

[66]  G. Goldstein,et al.  Recent advances in understanding brain capillary function , 1983, Annals of neurology.

[67]  D. Nochlin,et al.  The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.

[68]  P. Yates,et al.  IMMUNOHISTOCHEMICAL STAINING OF SENILE PLAQUES , 1982, Neuropathology and applied neurobiology.

[69]  A. Scheibel,et al.  DENERVATION MICROANGIOPATHY IN SENILE DEMENTIA, ALZHEIMER TYPE , 1987, Alzheimer disease and associated disorders.

[70]  D. Cogan,et al.  The mural cell in perspective. , 1967, Archives of ophthalmology.

[71]  C. Cotman,et al.  Plasticity of hippocampal circuitry in Alzheimer's disease. , 1985, Science.

[72]  W. Zeman ALTERATIONS OF BASEMENT MEMBRANES OF CEREBRAL CAPILLARIES , 1967, Journal of Neuropathology and Experimental Neurology.